Your browser doesn't support javascript.
loading
miR-133 regulates Evi1 expression in AML cells as a potential therapeutic target.
Yamamoto, Haruna; Lu, Jun; Oba, Shigeyoshi; Kawamata, Toyotaka; Yoshimi, Akihide; Kurosaki, Natsumi; Yokoyama, Kazuaki; Matsushita, Hiromichi; Kurokawa, Mineo; Tojo, Arinobu; Ando, Kiyoshi; Morishita, Kazuhiro; Katagiri, Koko; Kotani, Ai.
Afiliación
  • Yamamoto H; Department of Hematological Malignancy, Institute of Medical Science, Tokai University, 143 Shimokasuya, Isehara, Kanagawa 259-1193 Japan.
  • Lu J; Department of Intractable Diseases, Institute of National Center for Global Health and Medicine, 1-21-1 Toyama, Shinjuku-ku, Tokyo 162-8655 Japan.
  • Oba S; Department of Nephrology and Endocrinology, the University of Tokyo Hospital, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655 Japan.
  • Kawamata T; Department of Hematology/ Oncology, Institute of Medical Science, University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo 108-8639 Japan.
  • Yoshimi A; Department of Hematology and Oncology, Graduate School of Medicine, the University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo 108-8639 Japan.
  • Kurosaki N; Department of Hematological Malignancy, Institute of Medical Science, Tokai University, 143 Shimokasuya, Isehara, Kanagawa 259-1193 Japan.
  • Yokoyama K; Department of Hematology/ Oncology, Institute of Medical Science, University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo 108-8639 Japan.
  • Matsushita H; Department of Hematology / Oncology, School of Medicine, Tokai University, 143 Shimokasuya, Isehara, Kanagawa 259-1193 Japan.
  • Kurokawa M; Department of Hematology and Oncology, Graduate School of Medicine, the University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo 108-8639 Japan.
  • Tojo A; Department of Hematology/ Oncology, Institute of Medical Science, University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo 108-8639 Japan.
  • Ando K; Department of Hematology / Oncology, School of Medicine, Tokai University, 143 Shimokasuya, Isehara, Kanagawa 259-1193 Japan.
  • Morishita K; Department of Medical Science, Faculty of Medicine, University of Miyazaki, 5200 Kiyotakecho Kihara, Miyazaki-city, Miyazaki 889-1692 Japan.
  • Katagiri K; Department of Biosciences, School of Science, Kitasato University 1-15-1, Kitasato, Minami-ku, Sagamihara, Knagawa 252-0373 Japan.
  • Kotani A; Department of Hematological Malignancy, Institute of Medical Science, Tokai University, 143 Shimokasuya, Isehara, Kanagawa 259-1193 Japan.
Sci Rep ; 6: 19204, 2016 Jan 12.
Article en En | MEDLINE | ID: mdl-26754824
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Factores de Transcripción / Proto-Oncogenes / Leucemia Mieloide Aguda / Regulación Leucémica de la Expresión Génica / MicroARNs / Proteínas de Unión al ADN Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Sci Rep Año: 2016 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Factores de Transcripción / Proto-Oncogenes / Leucemia Mieloide Aguda / Regulación Leucémica de la Expresión Génica / MicroARNs / Proteínas de Unión al ADN Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Sci Rep Año: 2016 Tipo del documento: Article